Clinical and Laboratory Signs among Systemic Lupus Erythematosus Patients in Isfahan

Document Type : Original Article (s)

Authors

1 Associate Professor, Department of Internal Medicine, School of Medical Sciences, Isfahan, Iran

2 Resident, Department of Internal Medicine, School of Medicine And Student Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran

3 Assistant Professor, Department of Internal Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Systemic lupus erythematosus is an inflammatory disease with unknown etiology which affects different organs in the body. Since lupus has different features in various ethnic groups, we decided to evaluate lupus patients in Isfahan, Iran.Methods: In this study, 200 patients (183 women and 17 men) with definitive diagnosis of the disease were evaluated in the rheumatology clinic, Alzahra Hospital, Isfahan, Iran, during 2004-2005.Findings: The mean age of patients was 31.6 ± 10 years. Clinical signs and symptoms due to which the patients referred to the clinic for first time referred included musculoskeletal symptoms (65%), hematological symptoms (57%), mucocutaneous signs (52%), general symptoms (fever, fatigue, weakness and lethargy) (41%), renal symptoms (28%), cardiovascular symptoms (14%), neurological signs (12%), cardiac and pulmonary defects (11%) and gastrointestinal symptoms (3%).According to the results, anti-nuclear antibodies appeared in 92% of the patients, anti-dsDNA antibodies in 81%, CRP in 25%, lupus anticoagulant in 72.5%, and IgM and IgG anti-cardiolipin in respectively 24.2% and 31.2%. Anemia with hemoglobin levels less than 10 mg/dl was seen in 49 patients (24.5%), leukopenia with white blood cell counts less than 4000/mm3 in 38 patients (19%) and thrombocytopenia with platelets less than 150,000 mm3 in 18 patients (9%). Erythrocyte sedimentation rates above 30 mm3 were also detected in 55% of the patients. Conclusion: Considering the diversity of symptoms in patients with lupus and the impacts these symptoms have on the disease prognosis, accurate examinations need to be performed routinely and as soon as lupus is diagnosed.

Keywords

References

  1. Utz PJ. Multiplexed assays for identification of biomarkers and surrogate markers in systemic lupus erythematosus. Lupus 2004; 13(5): 304-11.
  2. Hahn BH. Systemic lupus erythematosus. In: Kasper DL, Braunwald E, Hauser SL, Longo DL, Jameson JL, Fauci AS, editors. Harrison's Principles of Internal Medicine. 16th ed. New York: McGraw-Hill Professional; 2005.
  3. Lahita RG. The role of sex hormones in systemic lupus erythematosus. Curr Opin Rheumatol 1999; 11(5): 352-6.
  4. Schumacher HR, Bardin T. The spondylarthropathies: classification and diagnosis. Do we need new terminologies? Baillière's Clinical Rheumatology 1998; 12(4): 551-65.
  5. Samanta A, Feehally J, Roy S, Nichol FE, Sheldon PJ, Walls J. High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus. Ann Rheum Dis 1991; 50(7): 490-2.
  6. Karimifar M, Bonakdar ZS, Nasiri S. Correlation of lupus activity based on british isles lupus assessment group index with serologic markers of lupus activity in patients of rheumatology clinic. Journal of Isfahan medical school 2010; 28(111): 563-570.
  7. Karimifar M, Gharibdoost F, Akbarian M, Meysamie AP, Khosravi Sh, karimifar M, et al. Triglyceride and high-density lipoprotein levels as the markers of disease activity and their association with TNF-α and TNF receptor system in systemic lupus erythematosus. APLAR Journal of Rheumatology 2007; 10(3): 221–6.
  8. Vitali C, Bencivelli W, Isenberg DA, Smolen JS, Snaith ML, Sciuto M, et al. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. The European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol 1992; 10(5): 541-7.
  9. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23(2): 137-45.
  10. Godaert GL, Hartkamp A, Geenen R, Garssen A, Kruize AA, Bijlsma JW, et al. Fatigue in daily life in patients with primary Sjogren's syndrome and systemic lupus erythematosus. Ann N Y Acad Sci 2002; 966: 320-6.
  11. Chwastiak L, Ehde DM, Gibbons LE, Sullivan M, Bowen JD, Kraft GH. Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. Am J Psychiatry 2002; 159(11): 1862-8.
  12. Roth RS, Geisser ME. Educational achievement and chronic pain disability: mediating role of pain-related cognitions. Clin J Pain 2002; 18(5): 286-96.
  13. Dickens C, Jayson M, Creed F. Psychological correlates of pain behavior in patients with chronic low back pain. Psychosomatics 2002; 43(1): 42-8.
  14. Bonakdar SZ, Tansaz J. Comparison of Mean Values of BILAG Index in Systemic Lupus Erythematosus (SLE) Patients with and without Metabolic Syndrome. Pejouhandeh 2008; 13(5): 417-23.
  15. Bamdad Mehrbany K, Akbarian M, Salesi M, Tavassoli S. Correlation of systemic lupus erythematosus disease activity with classical complement (CH50) function and related protein levels. Tehran University Medical Journal 2008; 66(6): 379-87.
  16. Saghafi M, Forughipour M, Rezayi Yazdi Z, Sakhdari A, Ahmadi Moghadam P. Neuropsychiatric manifestations in patients with systemic lupus erythematosus. Medical Journal of Mashad University of Medical Sciences 2008; 50(98): 355-60.
  17. Hatef MR, Rezaee Talab F, Tara SA, Azari Azad S. Clinical and laboratory study 79 patients with systemic lupus erythematosus. Medical Journal of Mashad University of Medical Sciences 1993; 36(43-44): 28-34.
  18. Yaghoobi R, Fathi J. Cutaneous manifestations of systemic Lupus Erythematosus: A study from Ahwaz. Iranian Journal of Dermatology 2000; 3(11): 35-41.
  19. Tabarestani M, Hatef MR, Keramati MR. Hematologie manifestations in systemic luplls erythematosus. Medical Journal of Mashad University of Medical Sciences 2003; 45(78): 5-12.
  20. Namian AM, Rahimi Nejad M. Laboratory findings in discoid Lupus Erythematosus: A study on 51 patients in skin clinic of Shahid Faghihi Hospital, Shiraz, 1998-2000. Iranian Journal of Dermatology 2001; 4(15): 3-10.
  21. Virgil L, Wood JR. Systemic lupus erythematosus and related syndromes. In: Kelley WN, Kelley ED, Ruddy SH, Sledge CB, editors. Textbook of Rheumatology.Philadelphia: W.B. Saunders; 1989. p. 1077-144.
  22. Amini OR, Rezazadeh M, Shakibi MR, Cheheltanan M. Epidemiologic evaluation the SLE patients referred to Kerman clinics of rheumatology [Thesis]. Kerman: School of Medicine, Afzalipour Medical University; 2007.
  23. Qari FA. Clinical pattern of systemic lupus erythematosus in Western Saudi Arabia. Saudi Med J 2002; 23(10): 1247-50.
  24. Dubois EL, Wallace DJ. Clinical and laboratory manifestations of SLE. Philadelphia: Lea and Febiger; 1987.
  25. Hahn BH. Systemic lupus erythematosus. In Harrison's Principles of Internal Medicine. 12th ed. New York: McGraw-Hill, Inc; 1991.
  26. Hannahs HB. Systemic Lupus Erythematosus. In: Fauci AS, Braunwald E, Kasper DL, editors. Principles of Internal Medicine. 15th ed. New York: MC Graw Hill; 2001. p. 1344-9.
  27. Lockshin WN, Harris ED, Sledge CB. Textbook of rheumatology. Philadelphia: WB Saunders; 2001.
  28. Adel M, Moula K, Saraj M, Halabian M, Ghaderian B. Evaluation of relation between cardiac disease and anti-Cardiolipin antibody in inactive Lupus patients. Journal of Isfahan Medical School 2004; 22(72): 7-10.
  29. Danesh Sani SH, Hatef MR, Skakib F, Dehestani R. Cardiac manifestations in fifty two systemic lupus erythematous patients. Medical Journal of Mashad University of Medical Sciences 2002; 45(76): 61-5.
Journal of Isfahan Medical School
Volume 29, Issue 164 - Serial Number 164
September and October 2012
Pages 2065-2072

Files

History

  • Receive Date: 04 March 2011
  • Revise Date: 01 November 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics